Ignite Creation Date:
2025-12-25 @ 12:45 AM
Ignite Modification Date:
2026-06-08 @ 3:52 AM
Study NCT ID:
NCT02617667
Status:
COMPLETED
Last Update Posted:
2019-11-06
First Post:
2015-11-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
CyclASol for the Treatment of Moderate to Severe Dry-eye Disease (DED)
Sponsor:
Novaliq GmbH
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CYS-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None